Himatsingka Q1 FY27: consolidated PAT falls 54% YoY to ₹4.99 Cr as margins compress

Himatsingka Seide's consolidated Q1 FY27 (quarter ended June 30, 2026) revenue came in at ₹621.30 Cr, down 5.4% YoY from ₹656.94 Cr — but ahead of the Street's Uniresearch preview of ~₹587 Cr (-10.7% YoY). Consolidated PAT missed instead: ₹4.99 Cr against a ~₹6 Cr street estimate, down 54.2% YoY from ₹10.90 Cr. Sequentially revenue rose 0.7% and PAT more than tripled off Q4 FY26's depressed ₹1.41 Cr base, but per our YoY-primary read, this quarter is a decline, not a recovery — the QoQ jump is largely base-effect off a weak prior quarter.

Margins compressed YoY: consolidated OPM (PBT plus finance cost and depreciation, less other income) slipped to 14.2% from 18.4% a year ago, and NPM fell to 0.80% from 1.66% — though OPM did improve from Q4 FY26's 8.05%. Reported PBT of ₹8.15 Cr was flattered by a ₹5.12 Cr cut in depreciation from a revised useful-life estimate on plant & equipment (disclosed identically in both standalone and consolidated notes); stripping that out, adjusted PBT is closer to ₹3.03 Cr and adjusted consolidated PAT growth is roughly -82% YoY versus the -54% reported figure. There were no exceptional items in either statement this quarter or in the comparatives. The consolidated decline was far steeper than standalone: standalone PAT of ₹5.18 Cr was down only 10.0% YoY, meaning the US subsidiaries and the AMPIN associate — which together contributed roughly ₹5.14 Cr of profit a year ago — turned into a roughly ₹0.19 Cr net drag this quarter.

The stock went into the print at ₹76.16, down 12.7% over the past month of trading.

Management's FY26 concall guidance centred on diversifying into yarn, fabric and apparel, targeted to become revenue-material only from H2 FY27, alongside a medium-term EBITDA margin band of 18-22% and explicit caution about near-term pressure from geopolitical and inflation factors — this quarter's margin compression is broadly consistent with that flagged caution, though the magnitude of the PAT decline is severe. No press release accompanied this filing to corroborate management's framing. During the quarter the company continued to term out debt via multiple NCD/debenture allotments (₹35 Cr, ₹15 Cr, ₹12.75 Cr and ₹12.5 Cr between July 10 and August 7, 2026) against a prior guidance target of cutting net debt to ~₹2,000 Cr within 12 months — not verifiable from this filing. With new-vertical contribution still not due until H2 FY27, this quarter offers no read on that transition; the next checkpoints are whether OPM recovers toward the 18-22% band and whether the US subsidiary/associate swing reverses.